Ceribell (CBLL) Change in Accured Expenses (2023 - 2026)
Ceribell (CBLL) posted Change in Accured Expenses of -$2.0 million for Q1 2026, down 156.29% on a QoQ basis from $3.5 million in Q4 2025, and down 11.07% year-over-year from -$2.2 million in Q1 2025.
Ceribell (CBLL) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Ceribell's Change in Accured Expenses history runs 4 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 11.07% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 58.08% YoY) and the FY2025 annual result came in at $4.2 million, up 71.04% from the prior year.
- Change in Accured Expenses was -$2.0 million for Q1 2026 at Ceribell, down from $3.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.5 million in Q4 2025 and bottomed at -$2.0 million in Q1 2026.
- A 4-year average of $681700.0 and a median of $1.3 million in 2025 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 317.22% in 2025, while the deepest fall reached 60.28% in 2025.
- Ceribell's Change in Accured Expenses stood at $2.1 million in 2023, then dropped by 5.57% to $2.0 million in 2024, then jumped by 76.84% to $3.5 million in 2025, then plunged by 156.29% to -$2.0 million in 2026.
- Business Quant data shows CBLL's Change in Accured Expenses at -$2.0 million in Q1 2026, $3.5 million in Q4 2025, and $765000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | 765,000.00 |
| Sep 30, 2025 | 765,000.00 |
| Jun 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | -1.76 Mn |
| Mar 31, 2025 | -1.76 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 418,000.00 |
| Jun 30, 2024 | 418,000.00 |
| Mar 31, 2024 | -1.84 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Dec 31, 2023 | 2.08 Mn |